We are IQVIA, The Human Data Science Company
Healthcare is an industry designed to help humans. As a global community, we continuously invest and commit to advancing human health. To deliver value and real outcomes. To rise to the challenge to find the next breakthrough by making the most of increasingly limited resources.
We are inspired by the potential and propelled by the possibilities. We share the vision to drive healthcare forward. To see how we can help accelerate progress and achievements. Others are developing these medical breakthroughs. We do our part by using breakthroughs in insights, technology and human intelligence to reimagine and deliver ways to help make them a reality.
It’s bigger than better clinical trials. Or advances in technologies and analytics. Or faster insights. It’s about unleashing the power of human data science. And that is why IMS Health and Quintiles have come together to be IQVIA, The Human Data Science Company.
Motivated by the industry we help, we’re committed to providing solutions that enable life sciences companies to innovate with confidence, maximize opportunities, and, ultimately, drive human health outcomes forward.
A pioneer among multinational healthcare companies with operations in Singapore, IQVIA has blazed a trail in Singapore’s life sciences industry.
Singapore is IQVIA's Asia Pacific headquarters and home to one of its five central labs in the region. Its team of more than 400 staff in Singapore provide services, technology solutions and market insights to biopharma and healthcare customers, and oversee IQVIA's operations across the region.
In 2016 IQVIA launched a new Singapore-based Asia branch of its global IQVIA Institute, which conducts research and publishes the results for use by governments, payers, academia and the life sciences industry.
IQVIA offers a full array of services from its Singapore headquarters to help life-science organizations succeed. These include its MedTech Asia unit, which supports the region’s burgeoning medical device & diagnostics industry, and Real-world Insights, which collects evidence about the effectiveness and value of marketed medicines used by patients in real-world settings.